Synthesis and Biological Evaluation of EC72: A New Folate-Targeted Chemotherapeutic
- 11 June 2005
- journal article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 16 (4), 803-811
- https://doi.org/10.1021/bc049709b
Abstract
A novel folate conjugate of mitomycin C, herein referred to as EC72, was designed and evaluated for biological activity against FR-positive cells and tumors. EC72 was produced by coupling folic acid-γ-cysteine to 7-N-modified MMC via a disulfide bond. This water soluble conjugate was found to retain high affinity for FR-positive cells, and it produced dose responsive activity in vitro against a panel of folate receptor (FR)-positive cell lines. EC72's activity was considered to be targeted and specific for the FR since (i) excess folic acid blocked biological activity, and (ii) FR-negative cell lines were unresponsive to this drug. Initial in vivo tests confirmed EC72's activity in both syngeneic and xenograft models, and this activity occurred in the apparent absence of gross or pathological toxicity. These results are significant, since daily dosing of EC72 for more than 30 consecutive days yielded no evidence of myelosuppression or toxicity to major organs, including the FR-positive kidneys. The latter observation supports published data, indicating that the apically oriented kidney proximal tubule FRs function to salvage folates prior to their excretion and to return these molecules back into systemic circulation. Overall, EC72's performance in vitro and in vivo warrants further preclinical study before this novel targeted chemotherapeutic is considered for clinical investigation.Keywords
This publication has 9 references indexed in Scilit:
- Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopyAmerican Journal of Physiology-Cell Physiology, 2004
- Folate-mediated Drug Delivery: Effect of Alternative Conjugation ChemistryJournal of Drug Targeting, 1999
- Folate‐maytansinoids: Target‐selective drugs of low molecular weightInternational Journal of Cancer, 1997
- Overexpression of folate binding protein in ovarian cancersInternational Journal of Cancer, 1997
- The folate receptor in central nervous system malignancies of childhoodJournal of Neuro-Oncology, 1994
- Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubuleAmerican Journal of Physiology-Cell Physiology, 1993
- High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding proteinBiochemical Journal, 1991
- Comparative Immunohistochemical Study of Four Monoclonal Antibodies Directed Against Ovarian Carcinoma-Associated AntigensInternational Journal of Gynecological Pathology, 1991
- STUDIES ON MITOMYCINS. IIIThe Journal of Antibiotics, 1968